NGB: A Potential Drug Target Or Biomarker for Neurological Disorders

Target Name: NGB

NCBI ID: G58157

Other Name(s): Neuroglobin | neuroglobin | NGB_HUMAN

NGB: A Potential Drug Target Or Biomarker for Neurological Disorders

Neuroglobin (NGB) is a protein that is expressed in the brain and is known for its role in the regulation of cell growth, differentiation, and survival. NGB has also been shown to play a key role in the development and progression of various neurological disorders , including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. As a result, NGB has generated a lot of interest as a potential drug target or biomarker for these disorders.

One of the key reasons for the interest in NGB is its ability to interact with a variety of molecules that are involved in the development and progression of these disorders. For example, NGB has been shown to interact with the protein tyrosine kinase (TK), which is involved in the regulation of cell growth and differentiation. Additionally, NGB has been shown to interact with the protein heat shock protein (HSP) 70, which is involved in the regulation of protein folding and stability.

In addition to its role in the regulation of cell growth and differentiation, NGB has also been shown to play a key role in the regulation of the immune system. For example, NGB has been shown to interact with the protein immune globulin (IgG) , which is involved in the regulation of immune responses. This interaction between NGB and IgG suggests that NGB may be a useful biomarker for assessing the severity of immune-related disorders.

Another potential application of NGB is its role in the regulation of the blood-brain barrier (BBB). The BBB is a barrier that separates the brain from the blood and is involved in the regulation of the flow of nutrients, drugs, and other substances into the brain. NGB has been shown to interact with the transmembrane protein detachment (CLDN), which is involved in the regulation of the BBB. This interaction suggests that NGB may be a useful drug target for treating disorders that are characterized by the disruption of the BBB.

In addition to its potential applications as a drug target or biomarker, NGB is also of interest because of its potential role in the development of neurodegenerative disorders. For example, NGB has been shown to be involved in the regulation of the neurotransmitter serotonin (5- HT), which is involved in the regulation of mood, appetite, and other physiological processes. Additionally, NGB has been shown to interact with the protein monoamine oxidase (MAO), which is involved in the regulation of neurotransmitter synthesis. This interaction suggests that NGB may be a useful target for treating disorders that are characterized by the disruption of normal neurotransmitter regulation.

Overall, NGB is a protein that has generated a lot of interest as a potential drug target or biomarker for a variety of neurological disorders. Its ability to interact with a variety of molecules involved in the development and progression of these disorders, as well as its The potential role in the regulation of the immune system and the blood-brain barrier, makes NGB a promising target for future research. Additionally, the potential role of NGB in the development of neurodegenerative disorders makes it an important area of 鈥嬧?媐ocus for future research.

Protein Name: Neuroglobin

Functions: Involved in oxygen transport in the brain. Hexacoordinate globin, displaying competitive binding of oxygen or the distal His residue to the iron atom. Not capable of penetrating cell membranes. The deoxygenated form exhibits nitrite reductase activity inhibiting cellular respiration via NO-binding to cytochrome c oxidase. Involved in neuroprotection during oxidative stress. May exert its anti-apoptotic activity by acting to reset the trigger level of mitochondrial cytochrome c release necessary to commit the cells to apoptosis

More Common Targets